Labiotech.eu

gensight biologics ipo euronext gene therapy

News and Trends 21 Jul 2016

UPDATED: French Gene Therapy for Blindness Launches another IPO

Update (21/07/2016): Gensight has successfully completed its IPO, raising €40M. This brings the Biotech’s total market capitalization to near €149M. The option of round oversubscription to €46M is still open. Originally published on 5/7/2016 After canceling its NASDAQ IPO back in April, GenSight is now launching on the Euronext Paris. It wants to raise €40M in total, […]

July 21, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 21 Jul 2016

Former uniQure and Evotec CEO pushes new viral candidate into Clinical Trials

Hookipa is starting its first clinical trial for a vaccine against human cytomegalovirus. This is the leading candidate of its platform for novel viral vectors, which promises to yield better vaccines for infections and cancer. Based in Vienna, Hookipa was founded in 2011 and is developing a new class of immunotherapies. Its strategy for novel […]

July 21, 2016 - 2 minutesmins - By Denise Neves Gameiro

pili tolouse white biotechnology twb bioreactor

News and Trends 20 Jul 2016

SynBio Startup moves to Toulouse to scale up its Bacterial Ink Production

Pili is leaving its bio-hacking nest in Paris for the industrial facilities of TWB, Toulouse’s preindustrial demonstrator for industrial Biotech. It will be able to develop pilot-scale production of its first dye – blue… Pili is one of the examples of Biotech innovation coming out of biohacking spaces. The start-up started at La Paillasse (Paris) and went on […]

July 20, 2016 - 2 minutesmins - By Denise Neves Gameiro

redhill biopharma nih ebola animal rule fda

News and Trends 20 Jul 2016

Israeli Biopharma joins NIH to develop Ebola Treatment

RedHill Biopharma has announced a research collaboration with the NIH. The focus will be RedHill’s new experimental treatment for Ebola, after encouraging results in preliminary studies. The Ebola outbreak of 2014 in West Africa highlighted the need for a therapy against this infectious disease, which has mortality rate ranging from 25% to 90%. The crisis spurred a […]

July 20, 2016 - 2 minutesmins - By Denise Neves Gameiro

immunoqure autoantibodies therapeutic apeced

News and Trends 19 Jul 2016

German Biotech studies Autoimmune Diseases to develop new Therapeutics

Patients suffering from a rare autoimmune disorder could actually be the key for a new promising type of antibodies. These are the findings of researchers from ImmunoQure and different European universities, now published in Cell. More than 40 years ago, the development of monoclonal antibodies really pushed the class of biologics forward. Research on antibodies […]

July 19, 2016 - 3 minutesmins - By Denise Neves Gameiro

poxel euronext paris diabetes type 2 glimins japan

News and Trends 19 Jul 2016

Poxel raises €26.5M to support Phase III trial in Diabetes

Poxel has closed a capital increase on the Euronext Paris, raising €26.5M. The money is intended to fund its plans to tackle the $4Bn Japanese market for Type 2 diabetes. Biotech is tackling diabetes with many different approaches, from new oral drugs to MedTech and cell therapy. In particular, type 2 diabetes (connected to a […]

July 19, 2016 - 2 minutesmins - By Denise Neves Gameiro

car t cd19 fda juno therapeutics cerebral edema

News and Trends 18 Jul 2016

UPDATED: Storm on the CAR-T field – 3 patients die in Phase II Study

A CAR-T program in Phase II trials (from Juno Therapeutics) was suspended by the FDA after 3 deaths, which could be treatment-related. How will this impact the field, given that most CAR-T Biotechs share the same target? UPDATE (article originally published on 8/7/2016): the FDA has allowed Juno Therapeutics to resume its CAR-T trial with […]

July 18, 2016 - 5 minutesmins - By Denise Neves Gameiro

News and Trends 18 Jul 2016

Switzerland discovers Pomegranate ‘Anti-Ageing’ Effect and founds Biotech

Researchers at the École Polytechnique Fédérale de Lausanne (EPFL) have uncovered a molecule in the pomegranate fruit which can prolong the lifespan of animal models. The co-authors who published in Nature went to co-found a biotech Amazentis to develop the wonder molecule into clinical trials. There are many underlying factors to what happens to our bodies as we age. However, […]

July 18, 2016 - 3 minutesmins - By Dani Bancroft

geg tech native advertising biotech digitaL MARKETING

News and Trends 18 Jul 2016

How did we increase the online traffic of this Biotech by 289%?

Helping Biotech companies become more visible is what we do every day — here’s a case study of how we successfully helped GEG-Tech. GEG-Tech is specialized in customized design and production of lentiviral vectors. Thanks to our solution, we helped brought more visitors to their website. The campaign was a great success, leading this company increase its sales and close a deal with a […]

July 18, 2016 - 3 minutesmins - By Joachim Eeckhout

News and Trends 15 Jul 2016

UK Biotech buys Swiss Antibodies to accelerate CAR-T Development

Cell Medica is a London-based biotech which develops, manufactures and markets personalised cell immunotherapeutics for infectious disease and cancer. It has therefore just acquired a Swiss antibody manufacturing biotech Delenex, to help its progress into the CAR-T field. Update 20/07/16: Cell Medica has also just received EMA Orphan Drug Designation for their CMD-003 candidate. This means it can obtain regulatory and […]

July 15, 2016 - 3 minutesmins - By Dani Bancroft

biotech infographic personalised edicine genetic disease

News and Trends 15 Jul 2016

Infographic: What are the key challenges in Personalized Medicine?

Personalized medicine is the way forward in tackling hard-to-treat indications. Here are some of the challenges in R&D of such therapies in biotech. By exploring use of autologous therapies, the chance of adverse responses from immunogenicity is reduced, making the treatment more targeted and effective (as doses can be higher). However, there are challenges in […]

July 15, 2016 - 1 minutemin - By Dani Bancroft

genomics proteomics merger syngis expedeon biotech

News and Trends 15 Jul 2016

These Two ‘Omics’ Companies are Merging to Create a New Player in Life Sciences

Sygnis is planning to acquire Expedeon, to join its portfolio in NGS reagents with Expedeon’s presence in the proteomics market – and become a leading player in life science reagents. UPDATE (article originally published on June 6th, 2016): Sygnis successfully completes Rights Offering and Private Placement and secured the acquisition of Expedeon Holdings Ltd. on July 15th, 2016. See […]

July 15, 2016 - 4 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

UPDATED: French Gene Therapy for Blindness Launches another IPO

Former uniQure and Evotec CEO pushes new viral candidate into Clinical Trials

SynBio Startup moves to Toulouse to scale up its Bacterial Ink Production

Israeli Biopharma joins NIH to develop Ebola Treatment

German Biotech studies Autoimmune Diseases to develop new Therapeutics

Poxel raises €26.5M to support Phase III trial in Diabetes

UPDATED: Storm on the CAR-T field – 3 patients die in Phase II Study

Switzerland discovers Pomegranate ‘Anti-Ageing’ Effect and founds Biotech

How did we increase the online traffic of this Biotech by 289%?

UK Biotech buys Swiss Antibodies to accelerate CAR-T Development

Infographic: What are the key challenges in Personalized Medicine?

These Two ‘Omics’ Companies are Merging to Create a New Player in Life Sciences

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!